HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Metolazone in arterial hypertension. Multi-centric study with 2.5 mg of Zaroxolyne (metolazone) taken in a single daily dose].

AuthorsG Abetel, C Allenbach, P Chapuis, P Christeler, B Delacrétaz, M Karly, G Magnenat, D Morandi, M A Muhlbauer, B de Senarciens, P Terrier, F Troillet
JournalRevue medicale de la Suisse romande (Rev Med Suisse Romande) Vol. 98 Issue 12 Pg. 685-91 (Dec 1978) ISSN: 0035-3655 [Print] Switzerland
Vernacular TitleLa métolazone dans l'hypertension artérielle. Etude multicentrique avec la Zaroxolyne 2,5 mg (métolazone) en prise quotidienne unique.
PMID366713 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Diuretics
  • Metolazone
Topics
  • Adult
  • Aged
  • Antihypertensive Agents (administration & dosage)
  • Clinical Trials as Topic
  • Diuretics (administration & dosage)
  • Drug Evaluation
  • Drug Tolerance
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Metolazone (administration & dosage, adverse effects)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: